Hook / Thesis
Cleveland-Cliffs (CLF) is a commodity cyclical that looks inexpensive on the path to normalized 2027 profitability if higher steel prices and tighter customer contracts persist. Management guided towards a meaningful step-up - projecting 2027 adjusted EBITDA in excess of $4.0 billion - and Q3 results showed the start of that recovery: revenue of $5.61 billion and adjusted EPS of $0.28. Those are not small numbers for a $6.7 billion market cap company.
My trade idea is to buy on near-term weakness and ride an earnings-and-margin re-rating into 2027. The actionable plan below targets upside to $17.50 over a long-term horizon (180 trading days), with a defined stop at $9.00 to respect Cleveland-Cliffs' leverage and cyclicality.
What the company does and why the market should care
Cleveland-Cliffs is vertically integrated across iron-making and flat-rolled steel production. They supply iron ore pellets and produce steel products for construction, automotive (including stamped and tubular components), and industrial customers. Vertical integration matters: when steel pricing is strong, Cliffs captures margin across the chain - from ore to finished steel.
Why does that matter now? Two simple drivers are in play: (1) realized steel prices are materially higher year-over-year - the company said average steel selling prices climbed 14.1% in the quarter - and that flow-through pushed the steelmaking segment's cash margin to approximately $685 million in Q3; (2) management is signaling improved contract discipline and unit economics that, if sustained, will convert higher prices into outsized free cash flow and EBITDA. Management's projection of Q4 adjusted EBITDA of roughly $715 million and a 2027 adjusted EBITDA that should exceed $4.0 billion is the explicit market hook.
Support from the numbers
- Q3 2026 revenue: $5.61 billion - up 18.5% year-over-year and slightly above consensus.
- Q3 adjusted EPS: $0.28, beating estimates by 16.7%.
- Steelmaking segment cash margin in Q3: $685 million. Management sees Q4 adjusted EBITDA around $715 million.
- 2027 guidance: management expects adjusted EBITDA to exceed $4.0 billion, implying a significant improvement versus recent trailing results.
- Market snapshot: market cap ~$6.7 billion, enterprise value ~$14.29 billion, and EV/EBITDA of ~23.1x on current reported EBITDA - high, but the multiple compresses quickly if 2027 EBITDA materializes above $4.0 billion.
- Balance-sheet and cash flow caution: trailing free cash flow was negative at -$485 million, debt-to-equity is elevated at 1.34x, cash reported is modest (~$0.02 billion1.87.
Valuation framing
On the surface CLF trades cheaply versus where it should be if the 2027 EBITDA target is credible. Market cap is ~$6.7 billion while enterprise value is ~$14.29 billion. If Cleveland-Cliffs delivers >$4.0 billion of adjusted EBITDA in 2027, pro forma EV/EBITDA would fall to ~3.6x - a valuation level typically associated with deep cyclical trough or heavy distress. The current headline EV/EBITDA of ~23.1x uses a lower trailing EBITDA figure and obscures the point: the investment case hinges on whether pricing and policy changes convert to sustainable 2027 cash flow.
Put another way, the market is giving little credit today for a 2027 earnings recovery even though management is explicitly guiding there. That gap creates asymmetric upside if the company executes on pricing discipline, volume recovery, and working capital improvements.
Catalysts
- Industrial pricing environment - sustained HRC and plate pricing above recent year averages will drive margin expansion and cash generation.
- Management's sales/contract policy changes - any concrete evidence of tighter contracts or transactable pricing reform will reduce revenue volatility and improve margins.
- Quarterly earnings cadence - Q4 and early-2027 releases that show rising shipment volumes, higher net selling prices and step-up in cash margin.
- Balance-sheet repair - meaningful free cash flow out of 2027 that starts to reduce net leverage will unlock multiple expansion.
Trade plan (actionable)
Below is a concise entry/stop/target plan. This is a directional long trade that assumes steel pricing remains constructive and that Cliffs' 2027 EBITDA outlook is at least partially realized.
| Action | Price | Horizon |
|---|---|---|
| Entry | $11.70 | Enter now or on small weakness |
| Stop Loss | $9.00 | Risk control - exit to limit downside |
| Target | $17.50 | Long term (180 trading days) - capture re-rating into 2027 |
Timeframes to consider within this plan:
- Short term (10 trading days) - look for a tactical bounce to the $12.50-$13.00 area if momentum improves; treat this as a near-term trading window only.
- Mid term (45 trading days) - measure progress from Q4 operational updates and early 2027 guidance; if the company reiterates or tightens its EBITDA target, add size.
- Long term (180 trading days) - hold to $17.50 if the sector remains constructive and Cleveland-Cliffs demonstrates improved cash generation and leverage reduction.
Risks and counterarguments
Cleveland-Cliffs is not without material risks. I list the principal downside scenarios and one counterargument to the bullish thesis.
- Commodities reversal: Steel prices are the dominant driver of CLF's profit cycle. A rapid drop in HRC or plate pricing would compress cash margins and invalidate the >$4.0 billion EBITDA outlook.
- Leverage and cash flow risk: The company reported trailing free cash flow of -$485 million and has thin reported cash (~$0.02 billion) with debt-to-equity of 1.34x. If pricing weakens, balance-sheet stress could reappear quickly.
- Execution on sales policy: The thesis assumes tighter commercial discipline or sales-policy reform that improves pricing realization. If changes are cosmetic or ineffective, margins will stay volatile.
- Volume risk and operational metrics: Some operational metrics fell short of analyst expectations even in the quarter where revenue rose. Volume misses or plant outages could offset price gains.
- Macro risk: Broader slowdown in construction, automotive demand, or passthrough cost pressures could reduce end-market demand for steel products.
Counterargument: Even if steel prices are sticky at current levels, CLF's balance sheet and negative trailing free cash flow mean the market may continue to apply a discount until there is undeniable evidence of sustained cash generation and leverage reduction. That path would push out the timeline for multiple expansion and compress near-term returns.
What would change my mind
I would downgrade the trade thesis if any of the following materialize: (1) a durable drop in steel prices by more than 10-15% versus current realized levels; (2) Q4 or early-2027 results that show persistent negative free cash flow with no sign of working capital improvement; (3) management abandons or fails to implement contract pricing discipline, leading to widening discounts to spot; or (4) net leverage increases materially from current levels because of capex overruns or M&A funded with debt.
Conclusion
Cleveland-Cliffs sits at an asymmetric point: management is guiding for a major improvement in 2027 EBITDA, and Q3 showed tangible margin expansion as average selling prices rose. The market capitalization of roughly $6.7 billion and enterprise value near $14.29 billion imply that a delivery of >$4.0 billion of adjusted EBITDA would produce a substantial multiple rerating. That makes CLF a candidate for a buy-on-weakness, defined-entry trade with a protective stop.
The trade is not without risk - cyclicality, leverage, and execution on sales policy are real. But if the company converts higher prices into consistent cash flow and begins to lower leverage, upside to $17.50 over a long-term horizon (180 trading days) is a reasonable, data-backed target.
Key near-term things to watch:
- Q4 operational metrics and pricing realization versus the Q3 baseline.
- Any detailed disclosures or commentary from management on sales policy or contract reform - that is the operational linchpin of the thesis.
- Free cash flow trajectory and any steps toward debt reduction.
Trade idea snapshot: Enter at $11.70, stop at $9.00, target $17.50. Long term (180 trading days) - add on validated progress toward 2027 EBITDA improvement.